Physician

Michael A Borofsky, M.D.

According to 2025 Medicare claims, Michael Borofsky, M.D. (NPI: 1578569455) practices rheumatology in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is ARTHRITIS AND OSTEOPOROSIS CENTER, INC. (NPI: 1194786491; TIN: 231949591) and primary practice location at 19610-3359.

Borofsky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 763 traditional Medicare patients, billed 335,564 HCPCS/CPT codes, and received $2,644,320 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,419 prescription claims across 497 beneficiaries totaling $1,199,207 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2018 DME data shows 11 claims. Open Payments data shows 71 records totaling $2,289. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,385,509 to $2,644,320. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $618,418 to $1,199,207. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,781 to $537.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2015 Medicare payment: $1,385,509 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,613,406 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,775,875 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,879,159 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,870,440 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,965,189 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,834,029 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,852,522 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,919,054 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,644,320 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201556682,642$1,385,509
2016602116,291$1,613,406
2017635130,205$1,775,875
2018659152,162$1,879,159
2019681171,249$1,870,440
2020641203,458$1,965,189
2021651190,339$1,834,029
2022661229,245$1,852,522
2023647240,434$1,919,054
2024763335,564$2,644,320

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$600K$1.2M2015 Drug cost: $618,418 (USD; Tot_Drug_Cst)2016 Drug cost: $513,027 (USD; Tot_Drug_Cst)2017 Drug cost: $562,016 (USD; Tot_Drug_Cst)2018 Drug cost: $731,691 (USD; Tot_Drug_Cst)2019 Drug cost: $921,735 (USD; Tot_Drug_Cst)2020 Drug cost: $1,131,562 (USD; Tot_Drug_Cst)2021 Drug cost: $1,035,618 (USD; Tot_Drug_Cst)2022 Drug cost: $917,436 (USD; Tot_Drug_Cst)2023 Drug cost: $1,083,312 (USD; Tot_Drug_Cst)2024 Drug cost: $1,199,207 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153912,610$618,418
20164022,743$513,027
20174022,838$562,016
20184462,708$731,691
20194022,782$921,735
20204483,166$1,131,562
20214513,167$1,035,618
20224543,080$917,436
20234443,204$1,083,312
20244973,419$1,199,207

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$252$5052016 Medicare payment: $505 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $396 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R11$505
2017N/RN/RN/R
2018N/R11$396
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more435956$94
J0897Injection, denosumab, 1 mg28524,367$20
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's291444$13
96372Injection of drug or substance under skin or into muscle332963$11
36415Insertion of needle into vein for collection of blood sample243382$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab471,596$448,857
Xeljanz XrTofacitinib Citrate32960$181,349
HumiraAdalimumab16448$107,390
OxycontinOxycodone Hcl18540$18,014
Hydroxychloroquine SulfateHydroxychloroquine Sulfate32216,617$12,718

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.70$1,565AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.1$724AstraZeneca UK Limited
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael A. Borofsky, M.D.?

Tedicare shows public-source Medicare data for Michael A. Borofsky, M.D. (NPI 1578569455), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael A. Borofsky, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael A. Borofsky, M.D.?

Michael A. Borofsky, M.D. is linked to ARTHRITIS AND OSTEOPOROSIS CENTER, INC. (billing NPI 1194786491) in the available physician profile data.

Does Michael A. Borofsky, M.D. have Open Payments data?

Michael A. Borofsky, M.D. has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.